The PRP SIA supports new ideas that represent synergistic approaches to PD research involving two to four Principal Investigators (PIs) at the Assistant Professor (or equivalent) level or above. These investigators should utilize their complementary and synergistic perspectives to address a central problem or question in Parkinson’s research. This award is designed to support both new and pre-existing partnerships and encourages participation of PIs from other research fields. The PRP Synergistic Idea Award seeks applications from investigators working in a wide spectrum of disciplines including, but not limited to, basic science, engineering, bioinformatics, population science, translational research, and clinical research.
Deadlines:
All applications to the FY22 PRP Synergistic Idea Award (SIA) program announcement MUST address at least one of the following FY22 PRP Focus Areas:
• Biological mechanisms or biomarkers of non-motor symptoms that could lead to the development of treatments for PD. Examples of non-motor symptoms of interest include: ○ Cognitive dysfunction relevant to PD ○ Psychiatric dysfunction ○ Sleep and circadian rhythms disruptions ○ Autonomic dysfunction ○ Sensory dysfunction ○ Fatigue
• Biological mechanisms or biomarkers associated with non-pharmacological interventions for non-motor symptoms of PD. Examples of non-pharmacological interventions of interest include: ○ Exercise ○ Diet ○ Neuro-stimulation therapy ○ Neurosurgical
Investigators must be at or above the level of Assistant Professor (or equivalent) to be named as the Initiating or Partnering PI on the application. Each Initiating or Partnering PI may be named as a PI on one PRP SIA application only.
An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization.
The anticipated total costs budgeted for the entire period of performance for an FY22 PRP SIA will not exceed $3M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
